SCHEMBL6014099

SCHEMBL6014099

NCCc1cc(=O)n(CC2CC2)c(=O)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP3A4 P08684 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GRIN1 Q05586 10/20 0.37
GRIN2B Q13224 10/20 0.37
PDE5A O76074 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
TLR8 Q9NR97 2/20 0.34
TLR7 Q9NYK1 2/20 0.34
MAP3K11 Q16584 2/20 0.33
MTOR P42345 1/20 0.33
MAPK9 P45984 1/20 0.32
GRIN2A Q12879 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1545981 0.78 MEN1 (0.61) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL5054519 0.75 SMN1; SMN2 (0.41) MEN1ALDH1A1KMT2ASMN1; SMN2PDE4A
SCHEMBL14820062 0.71 ALDH1A1 (0.49) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL17582663 0.70 YTHDF2 (0.43) MEN1ALDH1A1KMT2ASMN1; SMN2LMNA
SCHEMBL1945404 0.68 ALDH1A1 (1.00) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL14805622 0.68 ALDH1A1 (0.46) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL5906738 0.67 KMT2A (0.47) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL21667364 0.65 SMN1; SMN2 (0.46) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL4043882 0.65 ALDH1A1 (0.66) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2
SCHEMBL4041385 0.65 ALDH1A1 (0.65) MEN1ALDH1A1CYP3A4KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685132-A1 A sb 2B /sb ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2006-08-02 EP disclosed
WO-2005051951-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2005-06-09 WO disclosed